Tomasello Shawn

CIK 000161723911 companiesEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001617239

Recent Transactions

50 trades

Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2026-06-17+50,000→ 50,000 total
Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2026-06-09+22,000→ 22,000 total
Purchase
Cabaletta Bio, Inc.$CABA
Common Stock
2026-01-21$2.21/sh+22,725→ 22,725 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2025-06-17+22,500→ 22,500 total
Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2025-06-09+22,000→ 22,000 total
Disposition to Issuer
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2025-05-19−44,000→ 0 total
Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2025-05-19+22,000→ 22,000 total
Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2025-05-19+44,000→ 44,000 total
Disposition to Issuer
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2025-05-19−22,000→ 0 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-06-06+35,000→ 70,000 total
Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2024-06-03+22,000→ 22,000 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right To Buy)
2024-05-21+22,500→ 22,500 total
Award
Gamida Cell Ltd.
Ordinary Shares
2024-01-31+200,000→ 241,977 total
Award
Gamida Cell Ltd.
Share Option (Right to Buy)
2023-10-19+17,000→ 17,000 total
Award
Gamida Cell Ltd.
Ordinary Shares
2023-10-19+28,300→ 41,977 total
Award
Gamida Cell Ltd.
Share Option (Right to Buy)
2023-10-19+56,600→ 56,600 total
Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2023-07-21+44,000→ 44,000 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−12,100→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−4,177→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−16,800→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−15,191→ 0 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2023-05-23+22,500→ 22,500 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-05-11+35,000→ 35,000 total
Award
Gamida Cell Ltd.
Share Option (Right to Buy)
2023-03-20+17,000→ 17,000 total
Award
Gamida Cell Ltd.
Share Option (Right to Buy)
2023-02-08+56,600→ 56,600 total
Award
Gamida Cell Ltd.
Ordinary Shares
2023-02-08+28,300→ 41,977 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2022-12-15+16,800→ 16,800 total
Award
Gamida Cell Ltd.
Ordinary Shares
2022-11-18+2,000→ 13,677 total
Award
Gamida Cell Ltd.
Share Option (Right to Buy)
2022-11-18+9,500→ 9,500 total
Purchase
Gamida Cell Ltd.
Ordinary Shares
2022-09-30$1.55/sh+9,677→ 11,677 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2022-05-23+22,500→ 22,500 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-05-17+27,500→ 27,500 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-03-29+45,000→ 45,000 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2021-12-09+12,100→ 12,100 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2021-06-07+10,000→ 10,000 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2021-05-17+22,500→ 22,500 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2021-02-03+15,191→ 15,191 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2021-02-03+4,177→ 4,177 total
Disposition to Issuer
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-09-28−10,240→ 0 total
Disposition to Issuer
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-09-28−20,475→ 0 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2020-06-08+10,000→ 10,000 total
Award
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-06-04+10,240→ 10,240 total
Award
ABEONA THERAPEUTICS INC.$ABEO
Stock Option (right to buy)
2020-05-20+43,035→ 43,035 total
Award
ABEONA THERAPEUTICS INC.$ABEO
Common Stock
2020-05-20+35,938→ 35,938 total
Disposition to Issuer
Diplomat Pharmacy, Inc.
Common Stock
2020-02-10$4.00/sh−33,259→ 0 total
Disposition from Tender
Diplomat Pharmacy, Inc.
Common Stock
2020-02-10$4.00/sh−11,278→ 33,259 total
Sale
Diplomat Pharmacy, Inc.
Common Stock
2019-10-02$4.84/sh−859→ 44,537 total
Award
Principia Biopharma Inc.
Director Stock Option (right to buy)
2019-08-29+20,475→ 20,475 total
Award
Principia Biopharma Inc.
Director Stock Option (right to buy)
2019-08-29+10,240→ 10,240 total
Award
Principia Biopharma Inc.
Director Stock Option (right to buy)
2019-08-29+20,475→ 20,475 total

Companies

Recent Filings

Address

C/O 4D MOLECULAR THERAPEUTICS, INC. 5858 HORTON STREET #455

EMERYVILLE, CA, 94608

View on SEC.gov